University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research Partnership https://t.co/eXvfWvfXPC
Home
Latest News
Telix Pharmaceuticals and University of Melbourne Establish Cancer Translational Research Partnership
Melbourne, Australia, October 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased to announce that it has...Read More
October 18, 2017
Telix Pharmaceuticals Files $50 million Underwritten Initial Public Offering
Telix Pharmaceuticals Files $50 million Underwritten Initial Public Offering. Click here to view prospectus....Read More
October 16, 2017
Load More...